Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israele, Tel Aviv-Giaffa
Ofer Merimsky
41 anni di esperienza
accreditamenti :
Clinica certificata da :
| Israele | Turchia | Austria | |
| Chirurgia micrografica di Mohs | da $3,200 | da $2,200 | da $4,000 |
| Criodistruzione | - | da $3,500 | da $4,000 |
| Ampia escissione di melanoma | da $13,500 | da $4,000 | - |
Il Prof. Merimsky dirige l'Unità di Oncologia dei Tessuti Molli e delle Ossa presso il Centro Medico Sourasky, specializzata in casi complessi di Basalioma.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Il medico è un dermatologo altamente qualificato con specializzazione in oncodermatologia. Con una vasta esperienza nella diagnosi e nel trattamento dei tumori cutanei, il medico è esperto nelle più recenti procedure e terapie dermatologiche. Il medico è riconosciuto per un approccio incentrato sul paziente e per l'impegno nel migliorare la cura dermatologica attraverso la ricerca continua e la partecipazione ad associazioni professionali di dermatologia.<\/p>
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.
Mohs micrographic surgery is the most effective treatment for basalioma in Israel. This gold standard technique achieves 96–99% cure rates for primary tumors. It involves removing cancer layer by layer with immediate microscopic examination. This ensures 100% tumor-free margins while preserving healthy tissue.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report an average 90% success rate across all oncology treatments. Our data shows that top centers like Hadassah and Rambam serve nearly 1,000,000 patients annually. This massive volume translates to surgeons having extensive experience with rare or complex basalioma presentations. Patients benefit most when choosing university-affiliated facilities where doctors also conduct active clinical research.
Patient Consensus: Patients emphasize that a biopsy-first approach is essential to confirm tumor depth before starting Mohs. Many note that while topical creams work for superficial cases, surgical excision provides the most reliable long-term results.
Basalioma treatment in Israel achieves cure rates between 95% and 99%. Mohs micrographic surgery is the gold standard for facial lesions. It provides a 99% success rate for primary tumors. Standard surgical excision maintains a 95% cure rate for smaller lesions.
Bookimed Expert Insight: Israeli centers like Sourasky Medical Center report a 90% average success rate across all oncology treatments. Our data shows that top facilities like Assuta and Hadassah serve over 1,000,000 patients annually combined. This massive volume allows surgeons to master Mohs techniques, keeping recurrence for recurrent tumors as low as 5%.
Patient Consensus: Patients note that regrowth can appear within 18 months if margins are not clear. Many emphasize requesting Mohs surgery immediately to ensure the highest cure rate and best cosmetic results.
Diagnostics for basalioma in Israel generally take 3 to 4 business days. Treatment via Mohs surgery is often completed in a single 4-hour outpatient session. While primary surgical wounds heal in 3 to 6 weeks, complete skin maturation takes about 12 months.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report a 90% success rate for cancer treatments. For basalioma specifically, choosing JCI-accredited facilities in Tel Aviv ensures access to Mohs specialists. Since these centers perform over 30,000 surgeries annually, patient flow is highly optimized for fast-track diagnostics.
Patient Consensus: Patients often emphasize that procedures on the nose or near eyes require a full 6 weeks for visible healing. Many suggest requesting Mohs surgery for facial lesions to ensure the best cosmetic results and smaller scars.
Israeli medical centers like Sourasky, Sheba, and Hadassah lead in Mohs micrographic surgery for basalioma treatment. These facilities utilize fellowship-trained specialists to achieve nearly 99% cure rates. Most advanced Mohs units are located in Tel Aviv, Jerusalem, and Haifa university hospitals.
Bookimed Expert Insight: While public centers like Sourasky manage immense patient volumes, private facilities like Assuta Medical Center offer a distinct logistical advantage. Our data shows that at Assuta, patients can specifically select their attending physician. This is crucial for Mohs surgery, where the aesthetic outcome depends heavily on the individual surgeon's reconstructive skill.
Patient Consensus: Patients emphasize that the precision of the layer-by-layer removal provides peace of mind. Many note that choosing a surgeon with specialized fellowship training is vital for facial basalioma cases.
Basalioma removal in Israel rarely leaves significant scarring because specialists prioritize tissue-sparing techniques. Modern Mohs microsurgery preserves the maximum amount of healthy skin. While small marks are technically unavoidable, they often fade into fine lines that match natural skin tone within twelve months.
Bookimed Expert Insight: Israeli oncology centers like Sourasky and Hadassah maintain high success rates and prioritize aesthetic outcomes in facial cases. Patients often benefit from the presence of oncodermatologists like Dr. Reuven Bergman or professors like Dr. Ofer Merimsky. Our data shows these large university hospitals handle over 35,000 surgeries annually, ensuring doctors have the high volume necessary to master precise, minimal-scar techniques.
Patient Consensus: Patients emphasize that while some marks are inevitable, using silicone sheets and religious sunscreen use makes a huge difference. Many note that emphasizing cosmetic closure during the initial consultation helps ensure the best visual results.
Candidates for non-surgical basalioma treatment in Israel typically have superficial lesions under 1 mm deep. Photodynamic therapy (PDT) and topical creams like imiquimod are primary options for extensive field damage. These therapies prioritize cosmetic outcomes in sensitive areas like the face where surgery might cause scarring.
Bookimed Expert Insight: While non-surgical options are appealing, Israeli oncology centers like Sourasky or Assuta often perform over 30,000 surgeries yearly for a reason. Data reflects that high-volume centers prioritize histology revision to ensure aggressive subtypes aren't missed. If a lesion is nodular rather than superficial, these non-surgical methods frequently fail to reach the deep tumor root.
Patient Consensus: Patients note that while creams avoid surgical scars, they cause intense blistering and redness for several weeks. Many emphasize the professional biopsy is vital because using creams on deeper, high-risk spots often leads to recurrence within one year.
Most patients can fly 7 to 14 days after Mohs surgery in Israel. This window allows for initial healing and professional suture removal. While minor cases may receive clearance after 48 hours, international travel requires more time. Waiting ensures stable wound management before high-altitude cabin pressure changes.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center manage extremely high patient volumes, serving over 400,000 people annually. This high intensity means surgeons are exceptionally efficient. However, because surgeons there handle nearly 34,000 operations per year, they often advise a full 7-day stay. This ensures they can personally monitor the early stages of recovery before you depart.
Patient Consensus: Patients note that managing bandages in airport bathrooms is difficult and increases infection risks. Most suggest waiting until day 7 to ensure initial dressings are permanently removed and healing is stable.